Ozempic Alternatives for Weight Loss That Cost Less
With Ozempic still priced above $1,000 per month in the United States, many adults are looking for more affordable GLP-1 or non-GLP-1 options that deliver meaningful weight loss. Below, see exactly how much each alternative costs in October 2026 and how the results compare.
You don’t have to pay four figures for weekly semaglutide injections. Evidence-based alternatives-including Rx.com’s compounded semaglutide from $99 a month, tirzepatide from $149 a month, brand-name Wegovy, Zepbound, and older oral or injectable drugs-can trigger 5-20 % weight loss at a fraction of Ozempic’s sticker price. Understanding each option’s efficacy, safety, and 2026 cash cost helps you pick the plan that fits your budget and health goals.
- Ozempic’s current U.S. list price is $1,027.51 for a 28-day supply of pens. (bloomberg.com)
- Clinical trials show semaglutide 2.4 mg (Wegovy) delivers an average 14.9 % weight loss in 68 weeks. (nejm.org)
- Tirzepatide 15 mg (Zepbound) achieved 20.9 % weight loss in 72 weeks in the SURMOUNT-1 trial. (nejm.org)
- Rx.com offers compounded semaglutide from $99/month and compounded tirzepatide from $149/month on a 12-month plan-online visit and shipping included.
- Generic phentermine costs about $0.15 per 30 mg capsule (≈ $4.50 for a 30-day supply) based on CMS NADAC data. (data.medicaid.gov)
- Medicare’s GLP-1 Bridge caps patient cost at $50/month for select GLP-1s starting July 1, 2026. (cms.gov)
Ozempic’s price and access barriers push many adults to cheaper options
Ozempic is FDA-approved for type 2 diabetes, but millions of Americans use it off-label for weight loss. The drug’s wholesale acquisition cost exceeds $1,000 a month, and most insurers still refuse to cover weight-loss prescriptions. Even Novo Nordisk’s planned January 2027 list-price cut to $675 leaves a sizable out-of-pocket bill. (novonordisk-us.com)
Insurance hurdles: Prior authorization, quantity limits, and step-therapy rules delay or deny treatment for many. Medicare’s new GLP-1 Bridge helps, but only selected drugs are covered at $50/month. (cms.gov)
Supply constraints: Although official shortages resolved in 2025, sporadic back-orders can still force patients to switch doses or brands.
For readers newly exploring GLP-1 therapy, our first-time GLP-1 user guide breaks down injection basics, and the 2026 GLP-1 price table tracks monthly cash prices nationwide.
Several FDA-approved medications deliver proven weight loss for less money
Before resorting to gray-market sellers, compare the efficacy and real-world cost of FDA-approved drugs that undercut Ozempic’s price.
| Medication (dose) | Average weight loss | 2026 cash price* | Key notes |
|---|---|---|---|
| Wegovy (semaglutide 2.4 mg) | -14.9 % at 68 weeks (nejm.org) | $1,349 list; $349–$499 self-pay offers (washingtonpost.com) | Supply stable; Medicare copay $50 |
| Zepbound (tirzepatide 15 mg) | -20.9 % at 72 weeks (nejm.org) | $1,060 list; as low as $550 with Lilly savings (bloomberg.com) | Most potent weight-loss data to date |
| Saxenda (liraglutide 3 mg) | -8 % at 56 weeks (meta-analysis) (pubmed.ncbi.nlm.nih.gov) | ≈ $1,349 list; frequent $300 coupons (statnews.com) | Daily injection; supply abundant |
| Phentermine/topiramate 15 / 92 mg | -10.5 % at 56 weeks (CONQUER) (pubmed.ncbi.nlm.nih.gov) | Generic tabs ≈ $25–$40/month (NADAC) | Oral once daily; contraindications exist |
| Metformin ER 1,000 mg BID | -3–4 % sustained over 10 years (diabetesjournals.org) | Generic tabs <$10/month (NADAC) | Best for insulin resistance or prediabetes |
*Cash figures reflect manufacturer self-pay programs and CMS NADAC data where available, updated October 2026.
⚠️ Daily vs. weekly injections matter
Liraglutide (Saxenda) requires a daily shot, which many patients find harder to sustain than once-weekly semaglutide, tirzepatide, or oral options.
Compounded semaglutide and tirzepatide from Rx.com slash the monthly bill
When a prescriber determines you need a formulation unavailable from the manufacturer, a 503A compounding pharmacy can legally prepare an individualized medication. Because Ozempic pens are no longer on FDA’s shortage list, pharmacies may compound semaglutide only when they make a clinically necessary change (for instance, removing the injection pen excipients). (fda.gov)
Rx.com price transparency: Our 12-month plans include the online visit, every dose increase, and shipping:
- Compounded semaglutide from $99 per month
- Compounded tirzepatide from $149 per month
Every vial comes with bacteriostatic water and the correct needle size-no hidden “upsizing” fees. For an in-depth breakdown of how compounding costs compare to brand pens, see our first-month semaglutide cost breakdown and the 3-month tirzepatide bundle analysis.
| Self-pay option | Monthly price | Includes | Price per 5 % weight loss* |
|---|---|---|---|
| Brand Ozempic 2 mg pen | $1,027.51 (bloomberg.com) | 4 pens (0.5 mg each) | $205.50 |
| Rx.com compounded semaglutide | $99 | 8-week vial + supplies | $19.80 |
| Rx.com compounded tirzepatide | $149 | 8-week vial + supplies | $29.80 |
| Medicare GLP-1 Bridge (select brands) | $50 (cms.gov) | Retail pens, 28 days | $10.00 |
*Assumes 5 % loss after 12 weeks for cost-per-result illustration; individual results vary.
Generic appetite suppressants remain the cheapest prescription route
Stimulant-based suppressants like phentermine have been used for decades. While the average 10 % loss seen with phentermine/topiramate rivals some GLP-1 results, the side-effect profile (insomnia, palpitations) and contraindications (uncontrolled hypertension, coronary disease) limit who can take them.
Real-world cost: CMS NADAC shows pharmacies acquire 30 mg phentermine capsules for about $0.15 each-roughly $4.50 for a month of once-daily dosing. Consumers typically pay $15–$40 at the register, still over 95 % cheaper than Ozempic. (data.medicaid.gov)
Use our free Rx.com discount card to compare local cash prices instantly.
Is a lower-cost alternative right for you?
Check the column that fits your situation:
✅ Good candidate to switch
- BMI ≥ 27 kg/m² with weight-related condition
- No history of medullary thyroid cancer or MEN 2
- Insurance denies GLP-1 coverage
- Comfortable with self-injecting once weekly
- Willing to commit to lifestyle changes
🏥 Talk to your doctor first
- Severe GI disease or pancreatitis history
- Pregnant, breastfeeding, or trying to conceive
- Uncontrolled heart disease or arrhythmia
- Active gallbladder disease
- On multiple medications that interact with stimulants
Lifestyle programs amplify medication results and cut long-term costs
Every randomized GLP-1 and phentermine study layered medications on a calorie-deficit diet and increased activity. The National Diabetes Prevention Program shows that lifestyle coaching alone can achieve a 5-7 % weight loss, which cuts diabetes risk by 58 %. (pubmed.ncbi.nlm.nih.gov)
Meal size and timing: Smaller, protein-forward meals sync well with GLP-1-induced early satiety.
Resistance training: Two sessions per week preserve lean mass during rapid loss.
See our plateau-busting guide for practical tactics once weight loss slows.
🚨 When to Contact Your Healthcare Provider
Contact your doctor immediately if you experience any of the following:
- Severe abdominal pain - could signal pancreatitis or gallstones
- Persistent vomiting or inability to keep fluids down - risk of dehydration
- Vision changes - rare but reported with rapid glucose shifts
- Racing heartbeat or chest pain - possible stimulant side effect
- Swelling of face, lips, or throat - potential allergic reaction
- Thoughts of self-harm or depression - call or text 988 if in crisis
- Pale stools or dark urine - signs of liver or gallbladder issues
- Lump in the neck - report immediately due to thyroid-C cell tumor warning
Scientific References
- Wilding JP et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med, 2021.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med, 2022.
- Bloomberg News. Generic Ozempic Could Cost Less Than $3 a Month, 2026.
- Novo Nordisk. Company Press Release on List-Price Reduction, 2026.
- Centers for Medicare & Medicaid Services. $50 Monthly Access to GLP-1 Medications, 2026.
- CMS NADAC Database. National Average Drug Acquisition Cost 2026.
- Apolzan JW et al. Long-Term Weight Loss With Metformin in DPPOS. Diabetes Care, 2012.
Frequently Asked Questions
Is compounded semaglutide the same as Ozempic or Wegovy?
No. Compounded semaglutide is made by a 503A pharmacy for an individual patient when the prescriber determines a clinical need that the FDA-approved product cannot meet. It is not FDA-approved, and the pharmacy must change the formulation (for example, offering a multi-dose vial instead of a pen).
Will Medicare cover weight-loss drugs in 2026?
Yes, the CMS GLP-1 Bridge allows eligible Part D beneficiaries to access certain GLP-1 medications-currently Wegovy injection, Wegovy pill, and Zepbound-for a fixed $50 monthly copay through December 31, 2027.
Can I switch from Ozempic to compounded tirzepatide?
Potentially. Your provider will review medical history, current dose, and weight-loss progress to decide if switching is safe. A washout period is usually not required, but dose titration restarts at a low level.
How fast will I lose weight on phentermine?
Most patients lose 5–10 % of their starting weight over three months when phentermine is paired with a calorie-restricted diet. The medication is approved only for short-term use (up to 12 weeks).
Do GLP-1 drugs stop working over time?
Weight plateaus are common after 6–12 months as the body reaches a new set point. Dose adjustments, nutrition tweaks, or switching to a dual-agonist like tirzepatide may restart progress.
Are oral GLP-1 pills cheaper than injections?
Not always. Wegovy pill launches at $149 for the starter dose but rises to $299 for the highest dose. Compounded injectables can still be less per milligram.
What is the cheapest weight-loss drug overall?
Generic metformin and phentermine cost under $10 per month with a free Rx.com discount card, but they produce smaller average weight loss (2–10 %) than GLP-1s.
